Advertisement
Advertisement
Trending on Urology Times
1
FDA greenlights phase 1 trial of ADI-212 in mCRPC
2
Timothy McClure, MD, on 2-year PRESERVE trial results for focal IRE
3
Mary Dunn, MSN, RN, NP-C, OCN, on the role of APPs in genetic testing
4
State of Men’s Health Act: What urologists need to know
5